1.Ared WP,et al.An IL-1 inhibitorfrom human monocytes production and characterization of biologic properties.JImmunol,1980;143:1851
2.Baggiolini M and Dahinden CA.CCchemokines in allergic inflammation.Immunol Today 1994;15(3):127
3.Balkwill FR and Burke F.The cytokine network.ImmunolToday,1989;10(9):299
4.Bazan JF.Haemopoietic receptorsand helical cytokines .Immunol Today,1990;11(10):350
5.Cannon J G,et al.Circulatinginterleukin-1 and tumor necrosis of tumors.PNAS,1975;72:3666
7.Chan SH,et al.Induction ofinterferon γ production by natural killer cell stimulatoryfactor:characterization of the responder cells and synergy with other inducers.JExp Med,1991;173:869
8.Chen WF,et al.IL-10:A novelcytotoxic T cell diffeentiation factor.J Immunol,1991;147(2):528
9.Cosman D,et al.A new cytokinereceptor superfamily.TIBS,1990;15-July:265
10.Dinarello CA.Interleukin 1 andinterleukin-1antagonism.Blood,1991;77(8):1627
11.Dower SK,et al.Molecularcharacterization of two types of interleukin-1 recep-tor coding peptide onmurine and human cells.J Leukoc Biol(suppl.),1990;1:103
12.Durum SK and Mealy K.Hiltonhead revisited-cytokine explosion of the80s takes shape for the 90s.ImmunolToday,1990;11(4):103
13.Durum SK,et al.New cytokinesand receptors nake their debut in SanAntonio.Immunol Today,1991;12(2):54
14.Edward A,et al.How B and Tcells talk to each other.Nature,1994;367:425
15.Eisenberg SP.et al.Primarystructure and funtional expression from complementary DNA of a human inteleukin1 receptor antagonist Nature,1990;3:341
16.Engelmann H,et al.A Tumornecrosis factor binding protein purified to homogeneity from human urineprotects cells from tumor necrosis factor toxicity.J Biol Chem 1989;264:11974
17.Fiorentino DF,et al.IL-10 actson the antigen-presenting cell to inhibit cytokine production by Th1 cells.JImmunol,1991;146(10):3444
18.Fong Y,et al. Antibodies tocachetin/TNF reduce IL-1β and IL-6 appearance during lethal bacteremia J ExpMed 1989;170:1627
19.Gasson JC.Molecular physiologyof granulocyte-macrophage colony-stimulating factor.Blood,1991;77(6):1131
20.Gately MK,et al.Synergybetween recombinant interleukin 2(r IL-2)and IL-2 depleted lymphokinecontaining supernatants in facilitating allogeneic human cytolytic T lymphocyteresponses in vitro.j Immunol,1986;136:1274
21.Gately MK,et al.Regulation ofhuman lymphocyte proliferation by a heterodimeric cytokine,IL-12(cyotoxiclymphocyte maturation factor).j Immunol,1991;147:874
22.Gubler V,et al.Coexpression oftwo distinct genesis requird to generate secreted bioactive cytotoxiclymphocytquanxiangyun.cn/yishi/e maturation factor.PNAS,1991;88:4143
23.Hayashida K,et al.Molecularcloning of a second subunit of the receptor for human granulocyte-macrophagecolony-stimulating factor(GM-CSF):reconstitution of a high-affinity GM-CSfreceptor.PNAS,1990;87:9655
24.Himeno T,et al.Expression ofendogenous tumor necrosis factor.Cancer Res,1990;50:4941
25.Hirano T,et al.Biological andclinical aspects of interleukin 6.Immunol Today,1990;11(12):443
26.Horuk R.Theinterleukin-8-receptor family:from chemokines to malaria.ImmunolToday,1994;15(4):
27.Humnum CH et al.Interleukin-1receptor antagonist activity of a human interleukin-1inhibitor.Nature,1990;343:336
28.James K.Interaction betweencytokines and α2macroglobulin.Immunol Today,1990;11(50:163
29.Kishimoto T.The biology ofinterleukin-6.Blood,1989;74:1
tory factor(NKSF),a cytokine withmultiple biologic effects on human lymphocytes.J Exp Med 1989;170:827
31.KrantzS.Erythropoietin.Blood,1991;77(3):419
32.Liu Y and MullbacherA.Hypothesis:immunological help is reciprocally delivered between differentsubpopulations of lymphocytes.Scand j Immunol,1989;30:277
33.Lowenthal JM,et al.Binding andinternalization of interleukin 1 by Tcells direct evidence for high and lowaffinity classes of interleukin-1receptor.J Exp Med 1986;164:1060
34.Moore KW,et al.Homology ofcytokine synthesis inhibtory factor(IL-10)to the Epstein-Barr virus geneBCRFI.Science,1990;248:1230
35.Morgan RA,et al.Selective invitro growth of t lymphocytes.Science,1976;193:1007
36.Murphy PM.The molecularbiology of leukocyte chemoattractant receptors.Annu Rev Immunol,1994;12:593
37.Musash M,et al.Direct andsynergistic effects of interleukin 11 on murine hemopoiesis inculture.PNAS,1991;88:765
38.NacNeil IA,et al.IL-10,A novelgrowth factor for mature and immatureT cell.J Immunol,1990;145:4167
39.Namen AE,et al.Stimulation ofB-cell progenitors by cloned murine interleukin 7.Nature,1988;33:571
40.Paul SR,et al.Molecularcloning of a cDNA encoding interleukin 11,a stromal cell-derived lymphopoieticand hematopoietic cytokine.PNAS,1990;87:7512
41.Pizzolo G,et al.Solubleinterleukin 2 receptor in the serum of patients with Hodgkin"s disease.Br JCancer 1987;55:427
42.Ralop P.A summary of cytokineaspects of the intermational symposium of molecular hematology.1990;Lymphokineand Cytokine research,1991;10(1):77
43.Rot A.Endothelial cell bindingof NAP-1/IL-8 role in neutrophil emigration.Immunol Today 1992;13(8):291
44.Rubin LA,et al.The solubleinterlenkin-2 receptor biology,function and clinical application.Annals ofInternal.Medicine 1990;113(8):619
45.Rubin LA,et al.Solubleinterleukin 2 receptors are released from activated human lymphoid cells in vitro.J Immunol.1985;135:3172
46.Sims JE,et al.cDNA expressioncloning of the IL-1 receptor,a member of the immunoglobulin superfamily.Science1988;241:585
47.SmithKA.Interleukin-2:inception,impact and implications.Science,
1988;240:1169
48.Snouwaert JN,et al.Effects ofsite-specific mutations on biologic activity of recombinant human IL-6.JImmunol,1991;146(2):585
49.Stern AS,et al.Purification tohomogencity and partialcharacterization of cytotoxic lymphocyte maturation factor from humanB-lypmhoblastoid cell.PNAS,1990;87:6808
50.Stotter H,et al.IL-7induceshuman lymphokine-activated killer cell activity and is regulated by IL-4.JImmunol 1991;146(1):150
51.Takaki S,et al.Molecularcloning and expression of the murine interleukin-5 receptor.EMBO,1990;(13):4367
52.Taub DD and OppenheimJJ.Review of the chemokine meeting the third international symposium ofchemotactic cytokines.Cytokine,1993;5(3):175
53.Uckun FM,et al.Interleukin 7receptor ligation stimulates tyrosine phosphorylation,inositol phospholipidturnover,and clonal proliferation ofhuman B-cell precursors.PNAS,1991;88:3589
54.Uyttenhove C,et al.Functionaland structural characterization of P40,a mouse glycoprotein with T cell-growthfactor activity.PNAS,1988;85:6934
55.William E,et al.Structure andfunctional expression of a human interleukin-8 receptor.Science,1991;253:1278
56.Wong HL,et al.Characterizationof a factor(s) which synergizes with recombinant interleukin 2 promotingallogenic human cytolytic T-lymphocyte responses in vitro.CellImmunol,1988;11:39
57.Xing X and Yong SC:Humanrecombinant IL-3 is a growth factor for normal B cells.JImmunol,1992;148(2):491
58.Yin T,et al.Involvement ofIL-6 signal transducer gp130 in IL-11-mediated signal transduction.JImmunol,1993;151:2555
59.侯云德.干擾素的不同亞型與臨床應用。中國生物物品學雜志1991；6（4)：145
60.曹廣文、杜平.生藥活性多糖對淋巴細胞/細胞素的調(diào)節(jié)與抗腫瘤作用。免疫學雜志，1992；8（4)：273
61.孫紅、施渭康.白血病抑制因子.細胞生物學，1994；16（2)49
62.段海清、黃翠芳.抑瘤素M研究進展.因外醫(yī)學免疫學分冊，1994；17（4)：185
63.朱學軍、曹雪濤.腫瘤壞死因子拮抗劑的種類性質(zhì)及其治療作用.國外醫(yī)學免疫分冊，1994；17（1)：21
64.舒翠玲、金伯泉.白細胞介素12（IL-12)的研究概況.免疫學雜志，1992；8（2)：133
65.孫忱、金伯泉.可溶性細胞因子受體研究進展.國外醫(yī)學免疫學分冊，1994；17（2)：70
66.孫凱、金伯泉.細胞因子受體中的共用鏈現(xiàn)象及信號轉(zhuǎn)導
67.黃傳書、金伯泉.IL-3、IL-5和GM-CSF受體研究的進展。國外醫(yī)學免疫學分冊，1995；18（3)：121
68.張新海、金伯泉. 趨化因子研究進展-趨化因子家族（一)。國外醫(yī)學免疫學分冊，1995；18（3)：130
